University of Leicester
Browse

Screening for drugs to reduce aggression in zebrafish

Download (278.43 kB)
Version 2 2020-05-06, 13:10
Version 1 2020-03-26, 14:21
journal contribution
posted on 2020-05-06, 13:10 authored by William HJ Norton
Aggression is a common symptom of several human psychiatric disorders. However, the drugs available to treat aggression are non-specific and can have unwanted side effects. The zebrafish is an ideal model for behavioural pharmacology. They are small, aggression can be measured reliably, and drugs can be applied by immersion in the tank water. The ability to visualise and manipulate circuits in the intact brain represents an excellent opportunity to understand how chemical compounds modify the signalling pathways that control this behaviour. This review discusses protocols to measure zebrafish aggression, the neural circuits that control this behaviour and how pharmacological studies can inform us about environmental toxicology and the development of therapeutic drugs for humans. This article is part of the Special Issue entitled ‘Current status of the neurobiology of aggression and impulsivity’.

Funding

The ideas and research leading to this review received funding from the European Community’s seventh framework programme (FP7/2007–2013) under grant agreement no. 602805.

History

Citation

Neuropharmacology, 2019, Volume 156, 107394

Author affiliation

Department of Neuroscience, Psychology and Behaviour

Version

  • AM (Accepted Manuscript)

Published in

Neuropharmacology

Volume

156

Publisher

Elsevier

issn

0028-3908

eissn

1873-7064

Acceptance date

2018-10-15

Copyright date

2018

Publisher version

https://www.sciencedirect.com/science/article/pii/S0028390818308098#ack0010

Spatial coverage

England

Language

English